| Name | fluorescein 5-isothiocyanate |
|---|---|
| Synonyms |
5-FITC
Isothiocyanatofluorescein 5-Isothionatofluorescein Benzoic acid, 2-(6-hydroxy-3-oxo-3H-xanthen-9-yl)-5-isothiocyanato- FITC Fluorescein 5-isothiocyanate EINECS 248-207-7 Fluorescein Isothiosyanate fluorescein isothiocyanate isomer 1 fluorescein 6-isothiocyanate FITC ISOMER Fluorescein 5-Isothiocyanate (isomer I) 3',6'-Dihydroxy-5-isothiocyanato-3H-spiro[2-benzofurane-1,9'-xanthén]-3-one 5-FITC (isomer I) 5-Isothiocyanatofluorescein (isomer I) FITC 5-Fluorescein Isothiocyanate fluorescein 5-isothiocyanate FITC,Fluorescein 5-isothiocyanate FITC isomer I Fluorescein isothiocyanate,isomer 1 2-(6-Hydroxy-3-oxo-3H-xanthen-9-yl)-5-isothiocyanatobenzoic acid Fluorescein Isothiocyanate (isomer I) Fluorescein isothiocyanate isomer I Spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one, 3',6'-dihydroxy-5-isothiocyanato- FITC-I Fluorescein 5(6)-isothiocyanate Fluorescein-5-isothiocyanate MFCD00005063 Spiro[isobenzofuran-1(3H),9'-[9H]xanthen]-3-one, 3',6'-dihydroxy-5-isothiocyanato- Fluorescein Isothiocyanate 3',6'-Dihydroxy-5-isothiocyanato-3H-spiro[2-benzofuran-1,9'-xanthen]-3-one |
| Description | FITC is a derivative of fluorescein for the labeling of amines. |
|---|---|
| Related Catalog | |
| In Vitro | Annexin V-FITC/PI is employed to detect chondrocyte apoptosis[1]. The PEI-modified CDs are conjugated with fluorescein isothiocyanate (FITC) to fabricate CDs-FITC composites[2]. |
| Cell Assay | The frequency of chondrocyte apoptosis is measured by flow cytometry with Annexin V-fluorescein isothiocyanate (FITC) and propidium iodide. A total of 1×104 treated chondrocytes are collected from each group, washed in cold PBS and incubated with Annexin V-FITC and PI at room temperature for 15 min in the dark on ice. These samples are then analyzed using a fluorescence-activated cell sorter. Cell Quest software is used to analyze the percentage of apoptosis. All tests are repeated in triplicate. |
| References |
| Density | 1.5±0.1 g/cm3 |
|---|---|
| Boiling Point | 708.6±60.0 °C at 760 mmHg |
| Melting Point | >360 °C(lit.) |
| Molecular Formula | C21H11NO5S |
| Molecular Weight | 389.381 |
| Flash Point | 382.4±32.9 °C |
| Exact Mass | 389.035797 |
| PSA | 120.44000 |
| LogP | 4.00 |
| Vapour Pressure | 0.0±2.3 mmHg at 25°C |
| Index of Refraction | 1.754 |
| Storage condition | 2-8°C |
| Stability | Stability Stable, but moisture-sensitive. Incompatible with strong oxidizing agents, strong bases, amines, acids. |
| Water Solubility | practically insoluble |
| Symbol |
GHS08 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H317-H334 |
| Precautionary Statements | P261-P280-P342 + P311 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Faceshields;Gloves |
| Hazard Codes | Xn: Harmful; |
| Risk Phrases | R22;R36/37/38;R42/43 |
| Safety Phrases | S22-S45-S36/37/39-S26-S36/37 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
|
~%
3326-32-7 |
| Literature: WO2006/84339 A1, ; Page/Page column 30 ; |
|
~%
3326-32-7 |
| Literature: Tomasch, Miriam; Schwed, J. Stephan; Kuczka, Karina; Meyer Dos Santos, Sascha; Harder, Sebastian; Nuesing, Rolf M.; Paulke, Alexander; Stark, Holger ACS Medicinal Chemistry Letters, 2012 , vol. 3, # 9 p. 774 - 779 |
|
~%
3326-32-7 |
| Literature: ACS Medicinal Chemistry Letters, , vol. 3, # 9 p. 774 - 779 |
|
~%
3326-32-7 |
| Literature: ACS Medicinal Chemistry Letters, , vol. 3, # 9 p. 774 - 779 |
|
~%
3326-32-7 |
| Literature: ACS Medicinal Chemistry Letters, , vol. 3, # 9 p. 774 - 779 |
|
~%
3326-32-7 |
| Literature: ACS Medicinal Chemistry Letters, , vol. 3, # 9 p. 774 - 779 |